Keros Therapeutics
KROS
KROS
121 hedge funds and large institutions have $1.06B invested in Keros Therapeutics in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
34% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 32
13% more funds holding
Funds holding: 107 → 121 (+14)
11.77% more ownership
Funds ownership: 77.26% → 89.03% (+12%)
Holders
121
Holding in Top 10
4
Calls
$1.35M
Puts
$86K
Top Buyers
| 1 | +$55.7M | |
| 2 | +$42.2M | |
| 3 | +$14.1M | |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
+$14M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.7M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$13.4M | |
| 3 | -$9.78M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$9.48M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.97M |